Cadus Financial Ratios

Cadus Corporation -- USA Stock  

USD 1.46  0.01  0.69%

We suggest you to use analysis of Cadus fundamentals to see if markets are presently mispricing the company. We found twenty-five available fundamental indicators for Cadus Corporation which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Cadus fundamentals including its EBITDA as well as the relationship between Cash Flow from Operations and Retained Earnings . Please also double-check Cadus Corporation Price to Earning to validate the company can sustain itself down the road.Use Cadus to enhance returns of your portfolios. The stock experiences moderate upward volatility. Check odds of Cadus to be traded at $1.606 in 30 days

Cadus Company Summary

Cadus competes with Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Seattle Genetics, Sage Therapeutics, and . Cadus Corp purchases individual homes or residential lots for renovation or construction, and resale. As of March 15, 2016, its properties included 12 residential properties in MiamiDade County, Florida and 1 property in East Hampton, New York. Cadus Corp was formerly known as Cadus Pharmaceutical Corporationration and changed its name to Cadus Corporationration in June 2003. Cadus Corporationration was founded in 1992 and is based in New York, New York.

Cadus Return On Asset vs Cash and Equivalents

Cadus Corporation is rated third overall in return on asset category among related companies. It is rated below average in cash and equivalents category among related companies .

Cadus Systematic Risk

The output start index for this execution was six with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Cadus correlated with the market. If Beta is less then 0 Cadus generally moves in the opposite direction as compared to the market. If Cadus Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cadus is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cadus is generally in the same direction as the market. If Beta > 1 Cadus moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.
< 38% 

Chance of Financial Distress

Cadus Corporation has less than 38 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Details

Compare

Compare Cadus To Peers
Hunter Gary CEO and President and Director
David Blitz CFO, Principal Accounting Officer, Treasurer and Secretary
More Executives

Opportunity Range

December 14, 2017 Opportunity Range